Reuters logo
BRIEF-Luye Pharma Group's unit to buy two biological antibody products
August 4, 2017 / 2:11 PM / 4 months ago

BRIEF-Luye Pharma Group's unit to buy two biological antibody products

Aug 4 (Reuters) - Luye Pharma Group Ltd

* SHANDONG LUYE and Shandong Boan Biological Technology Co entered into asset transfer agreements

* Deal for a total consideration of rmb450 million, which is payable by stages.

* SHANDONG LUYE has agreed to acquire two biological antibody products Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below